glucagon has been researched along with (pPNET) Peripheral Primitive Neuroectodermal Tumors in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mirocha, J; Ren, SG; Yu, R | 1 |
1 other study(ies) available for glucagon and (pPNET) Peripheral Primitive Neuroectodermal Tumors
| Article | Year |
|---|---|
Glucagon receptor is required for long-term survival: a natural history study of the Mahvash disease in a murine model.
Topics: Animals; Blood Glucose; Cachexia; Disease Models, Animal; Disease Progression; Female; Glucagon; Humans; Hypoglycemia; Lethargy; Liver Neoplasms; Longevity; Male; Mice; Mice, Inbred DBA; Mice, Knockout; Neoplastic Syndromes, Hereditary; Neuroectodermal Tumors, Primitive, Peripheral; Pancreatic Neoplasms; Receptors, Glucagon; Skin Neoplasms | 2012 |